Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ingrid M. Blomgren"'
Autor:
E. K. Strand, I. S. H. Hatten, Kathrine A. Seeberg, Knut E.A. Lundin, Rolf Anton Klaasen, Tore K Kvien, Knut Tveit, C. Mørk, Espen A Haavardsholm, S. S. Hoie, G. L. Goll, Gert Huppertz-Hauss, Jon Hagfors, A. Poyan, Synøve Kalstad, B. Gulbrandsen, Geir Noraberg, Jørgen Jahnsen, David J. Warren, K. Waksvik, K. Ryggen, H. U. Rashid, Cecilia Vold, Ingrid Prytz Berset, Øivind Asak, Nils Bolstad, S. O. Frigstad, Bjørg Tilde Svanes Fevang, Bjørn Moum, Ulf Prestegård, Joseph Sexton, C. C. Zettel, I. P. Midtgard, Magne Henriksen, Ingrid M. Blomgren, M. Lorentzen, Roald Torp, Carl Magnus Ystrøm, K. Skjetne, T. J. Bruun, Katrine Dvergsnes, Pawel Mielnik, J. Krogh, Ø. Brenna, Inge C. Olsen, Inger Marie Jensen Hansen, S. Baigh, K. K. Jørgensen
Publikováno v:
Journal of Internal Medicine
BACKGROUND AND OBJECTIVES: The 52-week, randomized, double-blind, noninferiority, government-funded NOR-SWITCH trial demonstrated that switching from infliximab originator to less expensive biosimilar CT-P13 was not inferior to continued treatment wi
Autor:
Nils Bolstad, Svanaug Skorpe, Yngvill Hovde Bragnes, Øystein Sandanger, Anne Julsrud Haugen, Roald Torp, Lars Normann Karlsen, Silje W Syversen, G. L. Goll, Ingrid M. Blomgren, David J. Warren, Camilla Zettel, Inge C. Olsen, Turid Thune, Christian Kvikne Dotterud, Brigitte Michelsen, Jørgen Jahnsen, Rune Johan Njålla, Geir Noraberg, K. K. Jørgensen, Pawel Mielnik, Carl Magnus Ystrøm, Kathrine A. Seeberg, J. E. Gehin, Joseph O. Sexton, Tore K Kvien, C. Mørk, Maud Kristine Aga Ljoså, Rolf Anton Klaasen, Trude Jannecke Bruun, Marthe Kirkesæther Brun, Espen A Haavardsholm, E. K. Strand
Publikováno v:
Journal of the American Medical Association (JAMA)
Importance Proactive therapeutic drug monitoring (TDM), defined as individualized drug dosing based on scheduled monitoring of serum drug levels, has been proposed as an alternative to standard therapy to maximize efficacy and safety of infliximab an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7427e8aee61a86b9681517c460490d0
https://hdl.handle.net/11250/3048675
https://hdl.handle.net/11250/3048675
Autor:
Geir Hoff, Birgitte Seip, Asle W. Medhus, Jan-Magnus Kvamme, Gert Huppertz-Hauss, Lars Aabakken, Stein Dahler, Øyvind Holme, Per Sandvei, Øystein Kjellevold, Ole Darre-Næss, Ingrid M. Blomgren, Edoardo Botteri
Background Systematic training in colonoscopy is highly recommended; however, we have limited knowledge of the effects of “training-the-colonoscopy-trainer” (TCT) courses. Using a national quality register on colonoscopy performance, we aimed to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fd1006a03fdefd725c98861151a24b4
https://hdl.handle.net/10037/24450
https://hdl.handle.net/10037/24450
Autor:
Øivind Asak, Nils Bolstad, Jon Florholmen, Jørgen Jahnsen, Inge C. Olsen, G. L. Goll, Kathrine A. Seeberg, Liv Sagatun, Geir Noraberg, Knut E.A. Lundin, David J. Warren, Cecilia Vold, Magne Henriksen, Ulf Prestegård, Joseph Sexton, Jon Hagfors, Jan Henrik Rydning, Ingrid M. Blomgren, Rolf Anton Klaasen, Katrine Dvergsnes, Kristin Kaasen Jørgensen, Carl Magnus Ystrøm, Tore K Kvien, Gert Huppertz-Hauss, Bjørn Moum, Ingrid Prytz Berset, Roald Torp, Svein Oskar Frigstad, Espen A Haavardsholm
Publikováno v:
BioDrugs
Biodrugs
Biodrugs
Background: TNF-alpha inhibitors have improved treatment of chronic immune-mediated inflammatory disorders. The NOR-SWITCH main and extension trial addressed switching from infliximab originator (IFX) to CT-P13 across six diseases. Here we present th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9abe8284e6a86f126777aa9b144edd9a
https://hdl.handle.net/11250/2683922
https://hdl.handle.net/11250/2683922
Autor:
Pawel Mielnik, Jørgen Jahnsen, Ingvild S H Hatten, Cecilia Vold, Maud-Kristine A Ljoså, Ulf Prestegård, Jon Florholmen, Magne Henriksen, Bjørn Gulbrandsen, G. L. Goll, Kåre S Tveit, Ingrid Prytz Berset, Ingrid M. Blomgren, Hilde Stray, Julia R Kruse, Sigrun K Sæther, Inger M Hansen, Somyeh Baigh, Katrine Dvergsnes, Kenneth Waksvik, C. Mørk, Bjørg Ts Fevang, Clara Gram Gjesdal, Gert Huppertz-Hauss, Inge C. Olsen, Nils J Mørk, Sunniva S Hoie, Jon Hagfors, Jan Henrik Rydning, Tore K Kvien, Kristine Skjetne, Njaal Stray, Kristin Ryggen, Synøve Kalstad, M. Lorentzen, David J. Warren, Geir Noraberg, Berit H J Grandaunet, Roald Torp, Bjørn Moum, Karoline J. Henanger, Armin Poyan, Svein Oskar Frigstad, E. K. Strand, Espen A Haavardsholm, Knut E.A. Lundin, K. K. Jørgensen, Camilla C Zettel, Jan Krogh, Irina P Midtgard, Øivind Asak, Trude J Bruun, Nils Bolstad, Haroon U Rashid, Kathrine A. Seeberg, Liv Sagatun, Carl Magnus Ystrøm
Publikováno v:
The Lancet. 389:2304-2316
Summary Background TNF inhibitors have improved treatment of Crohn's disease, ulcerative colitis, spondyloarthritis, rheumatoid arthritis, psoriatic arthritis, and chronic plaque psoriasis, but are expensive therapies. The aim of NOR-SWITCH was to ex